Rimidi has partnered with BodyTrace, a cellular technology company, to provide cellular-enabled scales to heart failure patients who are remotely monitored by their clinicians using Rimidi's software platform. The cellular scales provide a frictionless experience for patients; all they have to do is step on the scale and their weight is automatically transmitted to the Rimidi platform, where their care team can monitor changes in weight that may indicate fluid retention and worsening heart
Read More
Rimidi
Rimidi Raises $6.575M for Cloud-based Enterprise Solution for Diabetes Management
Rimidi, Inc.(formerly known as Rimidi Diabetes), an Atlanta-based digital health startup that provides software and clinical analytics for chronic disease management, announced it has raised $6.575 million in Series A-1 financing, which includes a strategic investment by Eli Lilly and Company, an investment from Turner Investments, and participation from existing investors Cox Enterprises, Village Capital, The Jump Fund, and JAMB Global. The company plans to use the funding round to fuel growth
Read More
